Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome. 25980754

2015

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR Comprehensive BRCA1 and BRCA2 mutation analyses and review of French Canadian families with at least three cases of breast cancer. 20694749

2010

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR BRCA1/BRCA2 gene mutations/SNPs and BRCA1 haplotypes in early-onset breast cancer patients of Indian ethnicity. 22752604

2012

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR Genetic diagnosis of familial breast cancer using clonal sequencing. 20127978

2010

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. 19241424

2009

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR Contribution of BRCA2 germline mutations to hereditary breast/ovarian cancer in Germany. 11897832

2002

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR Founder mutations account for the majority of BRCA1-attributable hereditary breast/ovarian cancer cases in a population from Tuscany, Central Italy. 18821011

2009

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting. 16683254

2006

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance. 16489001

2006

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR Clinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significance. 24728577

2014

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR BRCA1 and BRCA2 mutations in breast cancer patients from Venezuela. 23096355

2012

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families. 18703817

2008

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. 11504767

2001

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR BRCA2 mutations in hereditary breast and ovarian cancer in France. 9150172

1997

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR BRCA2 splice site mutations in an Italian breast/ovarian cancer family. 19542536

2009

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer. 25682074

2015

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR Recurrent germline mutations in BRCA1 and BRCA2 genes in high risk families in Israel. 22399190

2012

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR Comprehensive splicing functional analysis of DNA variants of the BRCA2 gene by hybrid minigenes. 22632462

2012

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. 9585613

1998

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia. 23613520

2013

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR BRCA-associated pancreatico-biliary neoplasms: Four cases illustrating the emerging clinical impact of genotyping. 26004055

2016

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer. 23569316

2013

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR Computational and structural investigation of deleterious functional SNPs in breast cancer BRCA2 gene. 18724707

2008

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR Classifying Variants of Undetermined Significance in BRCA2 with protein likelihood ratios. 19043619

2008

Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
0.700 GeneticVariation CLINVAR Strong evidence that the common variant S384F in BRCA2 has no pathogenic relevance in hereditary breast cancer. 16168123

2005